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molecule kinase inhibitors against PDGF, VEGF and TGFβ 
receptors were administered orally either as single agents or 
in combination approaches. Survival and treatment-related 
side effects were followed up for more than 6 months. Lung 
density and septal fibroses were measured at various time 
points by HR-CT and MRI, and the molecular changes of 
irradiated lung tissue were analyzed using 
immunohistochemistry and gene expression analyses. 
 
Results: Treatment with individual inhibitors attenuated 
radiation-induced pulmonary inflammation, and reduced 
radiological and histological signs of pulmonary injury and 
fibrosis. Multi-pathway inhibition resulted in a significant 
additional attenuation of radiation-induced pulmonary 
damage and increased overall survival of treated mice 
compared to single-agent inhibition. Irradiation induced gene 
expression changes in lung tissue of downstream genes in 
particular for PDGF and TGFβ pathways; kinase inhibitors 
altered the expression of downstream proteins suggesting 
significant crosstalk between pathways during the 
development of radiation-induced lung injury. The expression 
of osteopontin as an established biomarker for pulmonary 
fibrosis was significantly upregulated by irradiation both on 
mRNA and protein levels; multi pathway inhibition 
completely normalized its overexpression when administered 
after radiation therapy. 
 
Conclusion: Multi-pathway signaling inhibition for PDGF, 
VEGF and TGFβ was shown to be an effective treatment for 
radiation-induced pulmonary damage and correlated well 
with reduced immune cell influx and expression of the 
pulmonary fibrosis biomarker osteopontin. Microarray-based 
gene expression analysis suggested extensive crosstalk 
between pathways upon thoracic Irradiation, warranting a 
combined Treatment approach. Multi-pathway inhibition 
suggests a novel treatment approach for the therapy of 
fibrotic lung diseases. 
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Purpose or Objective: During treatment of cancer patients 
using proton therapy, neutrons are generated as unwanted 
by-products. This out-of-field neutron exposure may affect 
the whole body of the patients and has been suggested to 
lead to enhanced formation of secondary cancer, especially 
in young patients. In recent years, indications for the 
involvement of stem cells in carcinogenesis have been 
increasing. Due to their long life span, stem cells may have 
an increased propensity to accumulate genetic damage 
relative to differentiated cells. Against this background, the 
intention of this study is to estimate the risks from neutrons 
compared to photons. Therefore, the investigation of damage 
induction on healthy adult stem cells from breast and thyroid 
tissue as an evidence of relative carcinogenic effectiveness 
following low and intermediate doses from neutrons 
compared to photons is performed. 
 
Material and Methods: Human breast cells with stem cell 
potential as well as murine thyroid stem cells are exposed to 
x-rays or neutrons (monoenergetic 0.56 MeV and 1.2 MeV 
neutron fields, neutron field with a broad energy distribution 
and a mean energy of 5 MeV) at various dose rates. In order 
to detect early indicators of carcinogenic modifications 
various in vitro analyses are utilised. By means of xenograft 
mouse models, tumour transformation for both cell types is 
analysed in vivo. 
 
Results: Previous results for cells originated from breast 
tissue show significant differences in survival, DNA repair and 
in the expression of stem cell marker MUC-1 and genes 
commonly associated with cancer following neutron 
exposure. The influence of radiation quality on the ability for 
self-renewal could be demonstrated by the use of a spheres 
formation assay. By analysing residual double strand breaks 
via the γH2AX assay, an effect on DNA repair could be 
observed, particularly after irradiation with neutrons with a 
low energy of 0.56 MeV. Furthermore the expression of the 
proteins p53, p27 and RB1 is modified considerably due to 
neutron irradiation. Similarly, exposure of thyrosphere 
derived cells showed differences in stem cell survival and 
remaining γH2AX foci after 24 hours. Long term passaging 
revealed changes in growth speed, stem cell marker 
expression and cancer associates genes changed in individual 
samples. 
 
Conclusion: Summing up, the study of stem cell behaviour 
may be a valuable tool in the investigation of carcinogenesis 
induced by ionizing radiation. The evaluation of the Relative 
Biological Effectiveness (RBE) of different types and energies 
of radiation may have a strong impact on our knowledge 
about the role of stem cells in carcinogenesis and will provide 
great benefit on the understanding of long-term risks of 
secondary cancers following low-dose exposure to neutrons 
during proton therapy.  
This work is financially supported from the 7th Framework 
Programme of European Commission (EURATOM) under 
contract FP7- 295970 (ANDANTE). 
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Purpose or Objective: Targeted therapies like immune 
checkpoint inhibitors are rapidly turning out to be important 
assets in the treatment of non-small scell lung cancer 
(NSCLC). The expression of these genes in both tumor and the 
surrounding non-malignant lung tissue might play an 
important role in determining their therapeutic window. This 
project aims to identify different expression patterns of 
these target genes. We therefore performed transcriptome 
analysis and investigated correlations with histology, gender, 
age, CRP level and smoking status in primary resected NSCLC 
and the surrounding non-malignant lung of the same patient. 
Additionally, differentially methylated gene sites were 
checked for impact on gene regulation.  
 
Material and Methods: Tissue of primary tumor as well as 
distant lung tissue was collected from 25 untreated, primary 
resected NSCLC patients. Illumina HiSeq 2000 was used to 
determine the differential gene expression between different 
conditions for 14 different target genes. DeSeq was chosen as 
the definitive method for statistical analysis. Differential 
methylation status was analyzed on an Infinium 
HumanMethylation 450K BeadChip. Differential gene 
expression and methylation status of the 14 chosen target 
genes were compared for 11 different conditions; results with 
P-values <0.05 after Benjamini-Hochberg correction were 
considered significant. For each differentially expressed 
gene, the locations of differentially methylated sites were 
checked in the UCSC Genome Browser. Histone markers 
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H3K4Me1, H3K4Me3 and H3K27Ac as well as presence of CpG 
islands were used to identify methylated regulatory 
elements. 
 
Results: Nineteen men and 6 women, with a median age of 
69 years, were included. Ten were current smokers, 14 ex-
smokers (stopped more than 4 weeks before surgery) and 1 
non-smoker. Fourteen patients had adenocarcinoma, eleven 
patients had squamous cell carcinoma. When compared to 
distant lung tissue, gene expression of PD-L2, HGF, VEGFR2 
and VEGFR3 were downregulated in tumor tissue. PD-L1 
expression was also downregulated in tumor tissue, but only 
in active smokers. For PD-L2, HFG, VEGFR2 and VEGFR3, 
methylation data shows a clear hypermethylation pattern in 
the promoter and enhancer regions of tumor tissue, which is 
conform the results of the transcriptome sequencing. 
Qualitative results of the expression and methylation data 
are depicted in figure 1. 
 
 
Conclusion: Our results show a lower expression of PD-L1 in 
tumors of active smokers. PD-L2, VEGFR2 and VEGFR3 and 
HGF have a lower expression in tumors overall. Methylation 
data confirms these findings. The therapeutic ratio with 
targeted treatment might be narrow as a result of this higher 
expression in distant lung tissue and in the case of immune 
checkpoint inhibitors, increase the chance of pneumonitis. 
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Purpose or Objective: Recent studies have shown that 
alterations in the pattern of radiation delivery, such as 
pulsed radiotherapy (PRT), can produce significant changes 
to the tumor microenvironment. Given the positive effects of 
PRT on maintaining tumor vasculature, we hypothesized that 
PRT treatment would allow tumor microenvironments to 
remain more oxygenated and result in better overall tumor 
killing compared with SRT. We further postulated that this 
effect would be associated with decreased tumor hypoxia, 
leading to lower vascular endothelial growth factor (VEGF) 
and stromal derived factor-1 alpha (SDF-1α) production and 
subsequently lower recruitment of bone marrow derived cells 
(BMDCs) in PRT-irradiated tumors.  
 
Material and Methods: Subcutaneous Lewis lung carcinoma 
(LLC) tumors were established in C57BL/6 mice. Tumors were 
allowed to grow to 100-200mm3 before irradiation with a 160 
kVp Faxitron cabinet (HVL: 0.77 mm Cu) using a dose rate of 
0.69 Gy/min. SRT or PRT was given to 20 Gy at 2 Gy/day 
using a 5 day-on, 2 day-off schedule to mimic clinical 
delivery. Tumors were harvested 2-3 days post treatment. 
Radiation-induced changes in the tumor microenvironment 
were examined using flow cytometry and antibody-specific 
histopathology. Normal tissue effects were determined using 
non-invasive 18F-FDG PET/CT and MR imaging after naïve 
animals were given whole-lung irradiation to 40 Gy using the 
same 2 Gy/day regimens.  
 
Results: PRT was more effective than SRT at reducing tumor 
growth rate (0.24±0.02mm3/day and 0.67±0.06mm3/day 
respectively; p<0.0001). Histopathology analysis showed a 
significant reduction in the levels of Ki-67 (13±8%), hypoxia 
(8±1%), VEGF (3.5±1%) and SDF-1α (4.2±1.5%) as well as a 
concomitant decrease in CD45+ BMDC migration (7.8±2.2%) 
after PRT when compared to SRT. Higher vessel density was 
also observed in PRT irradiated tumors. No short-term 
differences were observed in normal lung tissue after PRT or 
SRT although all irradiated animals demonstrated higher 
levels of inflammation than controls. 
 
Conclusion: Using a rapidly proliferating LLC allograft model, 
we have found evidence for improved tumor killing with PRT 
relative to SRT due to vascular maintenance. PRT irradiated 
tumors exhibited slower growth rate and reduced hypoxia 
coincident with loss of supportive mechanisms utilized by 
tumors in low oxygen microenvironments, such as 
angiogenesis and recruitment of BMDCs. This study 
demonstrates the efficacy of PRT and highlights the 
importance of microenvironment responses during tumor 
radiotherapy. We conclude that PRT represents an improved 
treatment strategy that may result in better overall patient 
outcomes with little alteration in normal tissue toxicity. 
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Purpose or Objective: The objective of this population-
based study was to provide an overview on trends and 
changing patterns in the adoption of postmastectomy 
radiotherapy (PMRT) over a 25-year period, and to validate 
the effectiveness of postoperative radiotherapy. Focused 
attention was given to disparities and barriers related to the 
use of postoperative radiotherapy in nodal positive disease 
and elderly patients. 
 
Material and Methods: The study included epidemiological 
data of 16,675 patients diagnosed with invasive breast cancer 
from 1988 to 2012, within the catchment area of the Munich 
Cancer Registry. Use of PMRT, local recurrence free survival 
(LRFS), cumulative incidence (CI) of time to local recurrence, 
relative survival and conditional overall survival (cOS), were 
analysed for different time periods (1988-1997 and 1998-
2012). Factors predicting the use of postoperative 
radiotherapy were analysed using multivariate logistic 
regression. 
 
Results: Use of PMRT was associated with significant 
improvements in local control, with a 10-year LRFS of 88.9% 
with PMRT vs. 84.1% following mastectomy alone (p<0.001). 
After adjusting for age, tumour characteristics and other 
therapies, the Cox-regression analysis for LRFS identified 
PMRT as an independent predictor for improved local control 
(hazard ratio [HR]: 2.145; 95% CI: 1.787-2.574, p<0.001). 
Patients with 1-3 involved lymph nodes had a 10-year CI of 
time to local recurrence of 13.7% following mastectomy 
alone, compared to 6.5% following PMRT (p= 0.001). 
Comparable findings were obtained for the subgroup of 
patients presenting with ≥ 4 positive lymph nodes – 
presenting with 17.8% 10-year CI of time to local recurrence 
in the mastectomy only group, compared to 8.2% in the PMRT 
group (p<0.001). All effects were smaller or extinct in elderly 
